A new study says the skyrocketing cost of prescription drugs in the U.S. can be blamed primarily on price increases — not new therapies or improvements to existing medications, as drug companies often claim.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Defying Trump, drugmakers hike prescription drug prices for 2019Nearly 30 drugmakers have taken steps to raise prices in January, ending a self-declared halt to increases made under pressure from President Trump.
Baca lebih lajut »
Sen. Bernie Sanders says 'we will end' Big Pharma 'greed' in legislative push to cut drug pricesThe bills, led by Sanders and Reps. Elijah Cummings and Ro Khanna, would permit Health and Human Services Secretary Alex Azar to negotiate lower prices for drugs under Medicare Part D, the federal program for prescription drug benefits.
Baca lebih lajut »
J&J raises US prices on around two dozen drugsJohnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products.
Baca lebih lajut »
House Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices.
Baca lebih lajut »
California to Flex Drug Purchasing PowerCalifornia's new governor plans to expand health coverage for undocumented immigrants, as the Democrat aims to take the lead on policies at odds with those of the Trump administration
Baca lebih lajut »
Here’s what happened when I tried to develop a new drug for a deadly cancer.Perspective: Here’s what happened when I tried to develop a new drug for a deadly cancer.
Baca lebih lajut »
New York trial of Mexican drug kingpin Joaquin 'El Chapo' Guzman resumes after holiday breakThe federal trial in New York for Mexican drug kingpin Joaquin 'El Chapo' Guzman resumed Thursday morning after a holiday break. The drug conspiracy trial is expected to last several more weeks.
Baca lebih lajut »